IRF7 and prostate carcinoma: Mirroring the findings from human prostate cancer cell lines, MeT increased expression of ERVs (murine ERV-L, MTA, RLTR1B, and RLTR45), LINE-1 elements, Rig-I and Irf7 in RM1 cells (Fig. 7E).